Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01410084 · ClinicalTrials.gov registry record · NA

Improving Vitamin D Status in Home-bound Elders

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
68
Enrollment target

NCT01410084 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 68 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01410084, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
68 participants
Enrollment target

Study Summary

In the past two decades, the role of vitamin D has extended beyond bone health to encompass a wide range of biological activities important to physical function in older adults. A growing body of evidence now shows that circulating 25-hydroxyvitamin D (25(OH)D) levels \< 75 nmol/L (\< 30 ng/mL)) are associated with physical impairments such as reduced walking speed and impaired balance as well as falls. Older adults are at risk for low levels of 25-hydroxyvitamin D because of reduced exposure to ultraviolet B radiation, reduced efficiency of previtamin D synthesis in the skin, and low dietary intake. Although data from the National Health and Nutrition Examination Survey (NHANES) 2000-2004 indicate that frank vitamin D deficiency (serum 25(OH)D \< 25 nmol/L \[10 ng/mL\]) is rare in the U.S. (5% or less), vitamin D insufficiency (serum 25(OH)D \< 75 nmol/L \[30 ng/mL\]) is prevalent (\~75%) among older adults. Older home-bound adults are a vulnerable subgroup of older adults for poor dietary intake and nutritional health, nutrition-related health conditions, and functional decline and disability. The primary goal of this pilot study is to assess the feasibility of a partnership with Senior Services of Forsyth County to address vitamin D insufficiency in home-bound older adults receiving home-delivered meals. A secondary goal is to obtain preliminary data on the effectiveness of vitamin D supplementation on improving vitamin D levels and reducing falls.

Interventions

  • DIETARY_SUPPLEMENT Vitamin D3
  • DIETARY_SUPPLEMENT Vitamin E

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2010-10
Est. Completion 2011-08
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT01410084

The ClinicalTrials.gov registry entry for NCT01410084 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Vitamin D3 is the first listed.

NCT01410084 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01410084 about?

NCT01410084 is a clinical study titled "Improving Vitamin D Status in Home-bound Elders". In the past two decades, the role of vitamin D has extended beyond bone health to encompass a wide range of biological activities important to physical function in older adults. A growing body of evidence now shows that circulating 25-hydroxyvitamin D (25(OH)D) levels \< 75 nmol/L (\< 30 ng/mL)) are...

What is the current status of trial NCT01410084?

This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2010-10. Estimated completion is 2011-08.

What interventions are being tested in trial NCT01410084?

The interventions under investigation include: Vitamin D3 (DIETARY_SUPPLEMENT), Vitamin E (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01410084?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.